Literature DB >> 32854499

Impact of Red Yeast Rice on Metabolic Diseases: A Review of Possible Mechanisms of Action.

Ju Hu1, Jin Wang1, Qing-Xia Gan1, Qian Ran1, Guan-Hua Lou1, Hai-Jun Xiong1, Cheng-Yi Peng1, Ji-Lin Sun2, Ren-Chuan Yao3, Qin-Wan Huang1.   

Abstract

Metabolic diseases constitute a major public health burden and are linked with high morbidity and mortality. They comprise atherosclerosis dyslipidemia, diabetes, hypertension, and obesity. However, there is no single drug that can simultaneously treat multiple diseases with complex underlying mechanisms. Therefore, it is necessary to identify a class of adjuvant drugs that block the development of metabolic diseases from a preventive perspective. Red yeast rice is a food fermentation product widely used to promote blood circulation and remove blood stasis. Modern pharmacology has shown that red yeast rice exerts potential protective effects on the liver, pancreas, blood vessels, and intestines. Therefore, this study was carried out to analyze and summarize the effect of red yeast rice on several metabolic diseases and the mechanisms of action involved. It was found that red yeast rice may be beneficial in the prevention and treatment of metabolic diseases.

Entities:  

Keywords:  metabolic diseases; multiple pathways; multiple targets; red yeast rice

Mesh:

Substances:

Year:  2020        PMID: 32854499     DOI: 10.1021/acs.jafc.0c01893

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  3 in total

1.  Ultrasonic extraction, structural characterization, and antioxidant activity of oligosaccharides from red yeast rice.

Authors:  Kai Liu; Long Xie; Huan Gu; Jia Luo; Xiaofang Li
Journal:  Food Sci Nutr       Date:  2021-11-24       Impact factor: 2.863

Review 2.  Red Yeast Rice Preparations Reduce Mortality, Major Cardiovascular Adverse Events, and Risk Factors for Metabolic Syndrome: A Systematic Review and Meta-analysis.

Authors:  Rong Yuan; Yahui Yuan; Lidan Wang; Qiqi Xin; Ya Wang; Weili Shi; Yu Miao; Sean Xiao Leng; Keji Chen; Weihong Cong
Journal:  Front Pharmacol       Date:  2022-02-21       Impact factor: 5.810

3.  Fufang Fanshiliu Decoction Revealed the Antidiabetic Effect through Modulating Inflammatory Response and Gut Microbiota Composition.

Authors:  Leyu Li; Guoxin Huang; Tingbo Chen; Hui Lin; Ruiyan Xu; Jinyan Cheng; Ying Hu; Weibo Dai; Gengting Dong
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-10       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.